Tramadol and Rheumatoid lung - a phase IV clinical study of FDA data

Summary:

Rheumatoid lung is reported as a side effect among people who take Tramadol (tramadol hydrochloride), especially for people who are female, 60+ old, also take Humira, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Rheumatoid lung when taking Tramadol. It is created by eHealthMe based on reports of 229,782 people who have side effects when taking Tramadol from the FDA, and is updated regularly.

What is Tramadol?

Tramadol has active ingredients of tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 235,800 Tramadol users. Check the latest studies of Tramadol.

What is Rheumatoid lung?

Rheumatoid lung (blockage of the small airways of the lung associated with rheumatoid arthritis) is found to be associated with 144 drugs and 148 conditions by eHealthMe. Check the latest studies of Rheumatoid lung.

On Aug, 01, 2026

229,782 people reported to have side effects when taking Tramadol.
Among them, 11 people (0.0%) have Rheumatoid lung.

Among these 11 people:

What is the gender of people who have Rheumatoid lung when taking Tramadol? *

female: 72.73 %
male: 27.27 %

What is the age of people who have Rheumatoid lung when taking Tramadol? *

What are other drugs people take besides Tramadol? *

What are other side effects people have besides Rheumatoid lung? *

Fatigue (feeling of tiredness): 4 people, 36.36%
Insomnia (sleeplessness): 4 people, 36.36%
Weakness: 4 people, 36.36%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 36.36%
Headache (pain in head): 4 people, 36.36%
Abdominal Pain Upper: 3 people, 27.27%
Head Injury: 3 people, 27.27%
Limb Injury: 3 people, 27.27%
Lacrimation Increased: 3 people, 27.27%
Keratitis (eye's cornea, the front part of the eye, becomes inflamed): 3 people, 27.27%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 9 people, 81.82%
Uveitis (inflammation of the uvea): 3 people, 27.27%
Psoriasis (immune-mediated disease that affects the skin): 3 people, 27.27%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 27.27%
High Blood Pressure: 3 people, 27.27%
High Blood Cholesterol: 3 people, 27.27%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 27.27%
Gastric Ulcer (stomach ulcer): 3 people, 27.27%
Fibromyalgia (a long-term condition which causes pain all over the body): 3 people, 27.27%

* Approximation only. Some reports may have incomplete information.

Do you take Tramadol and have Rheumatoid lung?

- Check whether Rheumatoid lung is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tramadol:

Tramadol (235,800 reports)

Rheumatoid lung treatments and more:

Rheumatoid lung (1,517 reports)

Browse all side effects of Tramadol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rheumatoid lung:

Rheumatoid lung (144 drugs)

Browse all the conditions that are associated with Rheumatoid lung:

Rheumatoid lung (148 conditions)

Related publications that referenced our studies

Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .
Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on tramadol hydrochloride (the active ingredients of Tramadol) and Tramadol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.